Building transparency into pharmaceutical supply chains with discoverable and verifiable Web3 assets

9

Global donor (pharmaceutical) organizations face a myriad of challenges and risks in their supply chains when monitoring donations of essential medical supplies to low-middle-income markets. Product diversion, improper storage and distribution conditions, quality excursions, expiration of products, and product tampering all put patients’ health at risk and impact donor organizations negatively in several ways. All of these supply chain risks prohibit the original intent of these donations – increasing access to medicines for patients in the low- and middle-income countries (LMICs).